One Way Ventures
131 Dartmouth Street Floor 3 Office 101, Boston, Massachusetts, 02116, United States
Overview
One Way Ventures is a seed-stage fund that invests in immigrant tech founders. The firm helps immigrant founders to start their businesses and companies in the US. It was founded in 2017 and headquartered in Boston, Massachusetts.
- Total investments
- 52
- Lead investments
- 10
- Investments · 12mo
- 5
- Active investors
- 7
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Debbie
Participated · Seed · Apr 2026
Debbie builds a consumer rewards program that shifts rewards toward lower-income users by tying points and cash back to every dollar of debt payoff, every dollar of savings, and improved financial decisions. The company launched Rewards 2.0 to operationalize that approach and reported having more than 200,000 users on its platform. Debbie is led by founders Frida Leibowitz and Rachel Lauren. The startup is based in New York. Debbie recently raised a $5.3 million seed round to support its current user base and to scale toward millions of users. The article frames the company as addressing inequities in the traditional credit card rewards ecosystem.
- ImmuneBridge
Participated · Seed · Mar 2026
ImmuneBridge develops a cell therapy screening and manufacturing platform that combines machine-learning-enabled donor selection with a proprietary small molecule that preserves stem-cell pluripotency through repeated replications. This approach enables differentiation into T cells, NK cells, macrophages, or neutrophils and can produce thousands of high-quality doses from a single donor versus the industry standard of tens of doses. The company is shifting to a "picks and shovels" model by licensing its platform to external co-development partners, from startups to large pharma, and is already working with over a dozen collaborators. Following its recent financing, ImmuneBridge promoted Dr. Nina Horowitz to CEO and appointed Dr. Rui Tostoes as CTO to lead the scale-up of manufacturing. Financially, the company raised $7.7M in a second seed round led by NFX, bringing total seed funding to nearly $20M. ImmuneBridge aims to advance initial human trials in 2028 and bring 10 therapies to the clinic within the next decade.
- Billdr
Participated · Seed · Jan 2026
Founded in 2020 in Montreal, Billdr has evolved from a home-renovation marketplace into a vertical SaaS provider focused on eliminating operational bottlenecks for general contractors. Its cloud platform centralizes customer relationship management, estimating, invoicing, project and team management, and payment processing, while layering in AI to automate routine workflows. The company currently serves hundreds of contractors across Canada and the United States. With its new capital, Billdr plans to deepen its AI capabilities, add financial infrastructure such as bill pay and lending, and introduce real-time building-material pricing. These enhancements are aimed at expanding the product’s value proposition and accelerating adoption across North America. Revenue figures were not disclosed, but the company’s user traction underscores demand for modernized contractor tools.
- Deduction
Led · Seed · Nov 2025
Deduction has emerged from stealth with the mission of resolving the certified public accountant shortage by automating tax preparation through artificial intelligence. Its software promises to replace the traditional, weeks-long and expensive CPA workflow, offering rapid, automated filing and real-time responses. Marketing lines such as “paying thousands for tax prep and waiting weeks for responses? That ends now” emphasize the product’s focus on affordability and speed. The platform positions itself as a full-service alternative to human tax professionals, leveraging AI to handle complex filings at scale. To fund this vision, Deduction secured $2.8 million in its first outside financing. The company has not yet disclosed user numbers, revenue traction, or detailed financial metrics.
- Provision
Participated · Seed · Oct 2025
Founded in 2022, Toronto-based Provision develops an AI platform that streamlines pre-construction workflows for estimators at large contractors. The software parses drawings, specs, and other project documents to surface risks, scope gaps, opportunities, and pricing details, effectively acting as a co-pilot in the estimating process. Current customers include international builders such as Ferrovial, EllisDon, PCL, Bird Construction, Acciona, and Colas. With its newly raised capital, the team plans to accelerate product development and introduce additional capabilities like its forthcoming Scope Agent tool. Provision’s value proposition centers on increasing bid accuracy and speed, helping contractors reduce costly errors and improve win rates. While no revenue or user metrics were disclosed, the company positions itself as a critical AI layer in the $16 T global construction market. The founders, Luigi La Corte and Brendan Ardagh, aim to deepen integration into core estimating workflows and expand adoption across major construction firms.